Illumina has named Susan Siegel to its board of directors. Siegel is chief innovation officer at General Electric and CEO of GE Ventures, which invests in startups and commercializes GE's intellectual property. Prior to joining GE, she was a general partner at Mohr Davidow Ventures, where she led investments in personalized medicine, digital health, and life sciences. Siegel was a founding representative member of the National Institutes of Health's National Center for Advancing Translational Sciences and also served on the Precision Medicine Initiative Working Group of the Advisory Committee to the NIH Director.
Twist Bioscience has appointed Martin Kunz as its senior VP of operations. Prior to Twist, he served as president of Eurofins Genomics US. Before serving as president, Kunz acted as chief technology officer at the firm. Prior to Eurofins, he served as chief information officer of Operon Biotechnologies. Kunz has also held a variety of positions at various companies in Switzerland.
SEngine Precision Medicine has appointed Siddhartha Mukherjee to its advisory board. Mukherjee is the Pulitzer Prize-winning author of the "The Emperor of All Maladies: A Biography of Cancer." Mukherjee is also an assistant professor of medicine and leading cancer researcher at Columbia University.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.